Fuhrmann N, Alavi M V, Bitoun P, Woernle S, Auburger G, Leo-Kottler B, Yu-Wai-Man P, Chinnery P, Wissinger B
Molecular Genetics Laboratory, Centre for Ophthalmology, Röntgenweg 11, Tübingen, Germany.
J Med Genet. 2009 Feb;46(2):136-44. doi: 10.1136/jmg.2008.062570.
Autosomal dominant optic atrophy (ADOA) is considered as the most common form of hereditary optic neuropathy. Although genetic linkage studies point to the OPA1 locus on chromosome 3q28-q29 as by far the most common gene locus, previous screening studies-based on sequencing of the coding exons-detected OPA1 mutations in only 32-70% of ADOA patients. We therefore hypothesised that larger deletions or duplications that remained undetected in previous screening approaches may substantially contribute to the prevalence of OPA1 mutations in ADOA.
42 independent ADOA patients were analysed for the presence of genomic rearrangements in OPA1 by means of multiplex ligation probe amplification (MLPA). Deletions or duplications were confirmed either by long distance polymerase chain reaction (PCR) and breakpoint sequencing or loss of heterozygosity analyses with flanking microsatellite markers. Patients underwent ophthalmological examination including visual acuity, colour vision testings, perimetry and funduscopy.
We identified genomic rearrangements in 8 of 42 patients, including single exon deletions of exon 9 and exon 24, respectively, a deletion of exons 1-5, two different deletions of the complete OPA1 gene as well as a duplication of the exons 7-9, with the latter being present in three unrelated families. Patients' phenotypes were highly variable, similar to patients with point mutation in OPA1.
Our findings show that gross genomic aberrations at the OPA1 gene locus are frequent in ADOA and substantially contribute to the spectrum and prevalence of OPA1 mutations in ADOA patients. They further strengthen the hypothesis that haploinsufficiency is a major pathomechanism in OPA1 associated ADOA.
常染色体显性遗传性视神经萎缩(ADOA)被认为是遗传性视神经病变最常见的形式。尽管基因连锁研究表明位于3q28 - q29染色体上的OPA1基因座是迄今为止最常见的基因座,但以往基于编码外显子测序的筛查研究仅在32% - 70%的ADOA患者中检测到OPA1突变。因此,我们推测在以往筛查方法中未被检测到的较大缺失或重复可能在很大程度上导致了ADOA中OPA1突变的发生率。
通过多重连接探针扩增(MLPA)分析42例独立的ADOA患者OPA1基因中基因组重排的存在情况。通过长距离聚合酶链反应(PCR)和断点测序或侧翼微卫星标记的杂合性缺失分析来确认缺失或重复。患者接受眼科检查,包括视力、色觉测试、视野检查和眼底镜检查。
我们在42例患者中的8例中鉴定出基因组重排,分别包括外显子9和外显子24的单个外显子缺失、外显子1 - 5的缺失、完整OPA1基因的两种不同缺失以及外显子7 - 9的重复,后者存在于三个无关家族中。患者的表型高度可变,类似于OPA1基因点突变的患者。
我们的研究结果表明,OPA1基因座的基因组大片段畸变在ADOA中很常见,并且在很大程度上导致了ADOA患者中OPA1突变的谱系和发生率。它们进一步强化了单倍剂量不足是OPA1相关ADOA主要发病机制的假设。